Literature DB >> 18004887

A disease state mutation unfolds the parkin ubiquitin-like domain.

Susan S Safadi1, Gary S Shaw.   

Abstract

E3 ubiquitin ligases are essential enzymes in the ubiquitination pathway responsible for the recognition of specific E2 conjugating enzymes and for transferring ubiquitin to a substrate targeted for degradation. In autosomal recessive juvenile Parkinson's disease, an early onset form of Parkinson's disease, point mutations in the E3 ligase parkin are one of the most commonly observed traits. Parkin is a multidomain E3 ligase that contains an N-terminal ubiquitin-like domain that interacts with, and effects the ubiquitination of, substrates such as cyclin E, p38 and synphilin. In this work we have examined the folding and structure of the parkin ubiquitin-like domain (Ubld) and of the protein with two causative disease mutations (K48A and R42P). Parallel experiments with the protein ubiquitin were done in order to determine if the same mutations were detrimental to the ubiquitin structure and stability. Despite similar folds between the parkin Ubld and ubiquitin, urea unfolding experiments show that the parkin Ubld is surprisingly approximately 10.6 kJ/mol less stable than ubiquitin. The K48A mutation had little effect on the stability of the parkin Ubld or ubiquitin indicating that this mutation contributes to defective protein-protein interactions. In contrast, the single point mutation R42P in parkin's Ubld caused poor expression and degradation of the protein. To avoid these problems, a GB1-Ubld fusion protein was characterized by NMR spectroscopy to show that the R42P mutation causes the complete unfolding of the parkin Ubld. This observation provides a rationale for the more rapid degradation of parkin carrying the R42P mutation in vivo, and its inability to interact with some substrate proteins. Our work provides the first structural and folding insight into the effects of causative mutations within the ubiquitin-like domain in autosomal recessive juvenile Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18004887     DOI: 10.1021/bi7016969

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

1.  Solution structure of the E3 ligase HOIL-1 Ubl domain.

Authors:  Steven A Beasley; Susan S Safadi; Kathryn R Barber; Gary S Shaw
Journal:  Protein Sci       Date:  2012-05-24       Impact factor: 6.725

2.  Attachment of an NMR-invisible solubility enhancement tag using a sortase-mediated protein ligation method.

Authors:  Yoshihiro Kobashigawa; Hiroyuki Kumeta; Kenji Ogura; Fuyuhiko Inagaki
Journal:  J Biomol NMR       Date:  2009-01-13       Impact factor: 2.835

3.  Differential interaction of the E3 ligase parkin with the proteasomal subunit S5a and the endocytic protein Eps15.

Authors:  Susan S Safadi; Gary S Shaw
Journal:  J Biol Chem       Date:  2009-10-29       Impact factor: 5.157

4.  The E3 ubiquitin ligase parkin is recruited to the 26 S proteasome via the proteasomal ubiquitin receptor Rpn13.

Authors:  Miguel A Aguileta; Jelena Korac; Thomas M Durcan; Jean-François Trempe; Michael Haber; Kalle Gehring; Suzanne Elsasser; Oliver Waidmann; Edward A Fon; Koraljka Husnjak
Journal:  J Biol Chem       Date:  2015-02-09       Impact factor: 5.157

5.  UbMES and UbFluor: Novel probes for ring-between-ring (RBR) E3 ubiquitin ligase PARKIN.

Authors:  Sungjin Park; Peter K Foote; David T Krist; Sarah E Rice; Alexander V Statsyuk
Journal:  J Biol Chem       Date:  2017-07-14       Impact factor: 5.157

6.  A snapshot of ubiquitin chain elongation: lysine 48-tetra-ubiquitin slows down ubiquitination.

Authors:  Jordan Kovacev; Kenneth Wu; Donald E Spratt; Robert A Chong; Chan Lee; Jaladhi Nayak; Gary S Shaw; Zhen-Qiang Pan
Journal:  J Biol Chem       Date:  2014-01-24       Impact factor: 5.157

7.  Monitoring PARKIN RBR Ubiquitin Ligase Activation States with UbFluor.

Authors:  Peter K Foote; Alexander V Statsyuk
Journal:  Curr Protoc Chem Biol       Date:  2018-07-31

8.  Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control.

Authors:  Gian-Luca McLelland; Vincent Soubannier; Carol X Chen; Heidi M McBride; Edward A Fon
Journal:  EMBO J       Date:  2014-01-20       Impact factor: 11.598

9.  Structure of phosphorylated UBL domain and insights into PINK1-orchestrated parkin activation.

Authors:  Jacob D Aguirre; Karen M Dunkerley; Pascal Mercier; Gary S Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-22       Impact factor: 11.205

10.  PINK1 is selectively stabilized on impaired mitochondria to activate Parkin.

Authors:  Derek P Narendra; Seok Min Jin; Atsushi Tanaka; Der-Fen Suen; Clement A Gautier; Jie Shen; Mark R Cookson; Richard J Youle
Journal:  PLoS Biol       Date:  2010-01-26       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.